Hande KR - Search Results

1

Combination chemotherapy with oral etoposide.

Johnson DH, Hainsworth JD, Hande KR, Greco FA. Johnson DH, et al. Among authors: hande kr. Semin Oncol. 1992 Dec;19(6 Suppl 14):19-24. Semin Oncol. 1992. PMID: 1336896 Clinical Trial.

2

Prolonged administration of low dose infusional etoposide in patients with advanced malignancies. A phase I/II study.

Thompson DS, Hainsworth JD, Hande KR, Holzmer M, Greco FA. Thompson DS, et al. Among authors: hande kr. Cancer. 1994 Jun 1;73(11):2824-31. doi: 10.1002/1097-0142(19940601)73:11<2824::aid-cncr2820731127>3.0.co;2-t. Cancer. 1994. PMID: 8194024 Clinical Trial.

3

Prolonged administration of low-dose, infusional etoposide in patients with etoposide-sensitive neoplasms: a phase I/II study.

Thompson DS, Hainsworth JD, Hande KR, Holzmer MC, Greco FA. Thompson DS, et al. Among authors: hande kr. J Clin Oncol. 1993 Jul;11(7):1322-8. doi: 10.1200/JCO.1993.11.7.1322. J Clin Oncol. 1993. PMID: 8315429 Clinical Trial.

4

Bioavailability of low-dose oral etoposide.

Hande KR, Krozely MG, Greco FA, Hainsworth JD, Johnson DH. Hande KR, et al. J Clin Oncol. 1993 Feb;11(2):374-7. doi: 10.1200/JCO.1993.11.2.374. J Clin Oncol. 1993. PMID: 8426216

5

Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase II trial.

Johnson DH, Paul DM, Hande KR, Shyr Y, Blanke C, Murphy B, Lewis M, De Vore RF 3rd. Johnson DH, et al. Among authors: hande kr. J Clin Oncol. 1996 Jul;14(7):2054-60. doi: 10.1200/JCO.1996.14.7.2054. J Clin Oncol. 1996. PMID: 8683236 Clinical Trial.

6

Paclitaxel plus carboplatin in the treatment of patients with advanced lung cancer: a Vanderbilt University Cancer Center phase II trial (LUN-46).

Johnson DH, Paul DM, Hande KR, DeVore R. Johnson DH, et al. Among authors: hande kr. Semin Oncol. 1996 Dec;23(6 Suppl 16):42-6. Semin Oncol. 1996. PMID: 9007120 Clinical Trial.

7

Paclitaxel, 5-fluorouracil, and folinic acid in metastatic breast cancer: BRE-26, a phase II trial.

Johnson DH, Paul D, Hande KR. Johnson DH, et al. Among authors: hande kr. Semin Oncol. 1997 Feb;24(1 Suppl 3):S22-5. Semin Oncol. 1997. PMID: 9071336 Clinical Trial.

8

Paclitaxel/5-fluorouracil/leucovorin in metastatic breast cancer: a Vanderbilt Cancer Center phase II trial.

Nicholson B, Paul D, Shyr Y, Garrett M, Hande KR, Johnson DH. Nicholson B, et al. Among authors: hande kr. Semin Oncol. 1997 Aug;24(4 Suppl 11):S11-20-S11-23. Semin Oncol. 1997. PMID: 9314294 Clinical Trial.

9

Preliminary analysis of a phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small cell lung cancer.

Choy H, DeVore RF 3rd, Hande KR, Porter LL, Rosenblatt P, Yunus F, Schlabach L, Smith C, Shyr Y, LaPorte K, Johnson DH. Choy H, et al. Among authors: hande kr. Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-21-S12-26. Semin Oncol. 1997. PMID: 9331115 Clinical Trial.

10

Weekly irinotecan and concurrent radiation therapy for stage III unresectable NSCLC.

Choy H, Chakravarthy A, Devore RF 3rd, Jagasia M, Hande KR, Roberts JR, Johnson DH, Yunus F. Choy H, et al. Among authors: hande kr. Oncology (Williston Park). 2000 Jul;14(7 Suppl 5):43-6. Oncology (Williston Park). 2000. PMID: 10981290 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters